BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21751909)

  • 1. Case records of the Massachusetts General Hospital. Case 21-2011. A 31-year-old man with ALK-positive adenocarcinoma of the lung.
    Shaw AT; Forcione DG; Digumarthy SR; Iafrate AJ
    N Engl J Med; 2011 Jul; 365(2):158-67. PubMed ID: 21751909
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
    Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
    Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer.
    Kim SJ; Kim DW; Kim TM; Lee SH; Heo DS; Bang YJ
    J Clin Oncol; 2012 Jun; 30(16):e147-50. PubMed ID: 22508824
    [No Abstract]   [Full Text] [Related]  

  • 4. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.
    Cooper WA; O'toole S; Boyer M; Horvath L; Mahar A
    Pathology; 2011 Feb; 43(2):103-15. PubMed ID: 21233671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
    Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case records of the Massachusetts General Hospital. Case 31-2011. A 55-year-old man with oligometastatic lung cancer.
    Lanuti M; Sequist LV; Sharma A; Mino-Kenudson M
    N Engl J Med; 2011 Oct; 365(15):1426-35. PubMed ID: 21995391
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystic brain metastasis in non-small-cell lung cancer with ALK rearrangement.
    Hayashi H; Okamoto I; Tanizaki J; Tanaka K; Okuda T; Kato A; Nishimura Y; Nakagawa K
    J Clin Oncol; 2014 Dec; 32(36):e122-4. PubMed ID: 24567432
    [No Abstract]   [Full Text] [Related]  

  • 8. Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases.
    Kim H; Xu X; Yoo SB; Sun PL; Jin Y; Paik JH; Choe G; Jheon S; Lee CT; Chung JH
    Histopathology; 2013 Jan; 62(2):305-14. PubMed ID: 23020707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.
    Shinmura K; Kageyama S; Tao H; Bunai T; Suzuki M; Kamo T; Takamochi K; Suzuki K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
    Lung Cancer; 2008 Aug; 61(2):163-9. PubMed ID: 18242762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive monitoring of tumors.
    Schiller JH
    N Engl J Med; 2008 Jul; 359(4):418-20. PubMed ID: 18596267
    [No Abstract]   [Full Text] [Related]  

  • 11. [A Case Report of Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement].
    Miao Y; Ling L; Zhang X; Huang J
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):366-370. PubMed ID: 28532546
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.
    Kosaka T; Yatabe Y; Endoh H; Kuwano H; Takahashi T; Mitsudomi T
    Cancer Res; 2004 Dec; 64(24):8919-23. PubMed ID: 15604253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary Precision Medicine: A Role for Repeat Epidermal Growth Factor Receptor Analysis in ALK-Rearranged Lung Adenocarcinoma?
    Birkbak NJ; Hiley CT; Swanton C
    J Clin Oncol; 2015 Nov; 33(32):3681-3. PubMed ID: 26417000
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast metastasis from lung adenocarcinoma: a case report.
    Masmoudi A; Mathieu MC; Soria JC
    Anticancer Res; 2003; 23(2C):1825-6. PubMed ID: 12820464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 48-1987. A 27-year-old man with a pulmonary mass of 3 1/2 years' duration.
    N Engl J Med; 1987 Nov; 317(22):1399-406. PubMed ID: 3683471
    [No Abstract]   [Full Text] [Related]  

  • 17. Case records of the Massachusetts General Hospital. Case 23-2008. A 26-year-old man with back pain and a mass in the lung.
    Sequist LV; Settleman JE; Ackman JB; Iafrate AJ
    N Engl J Med; 2008 Jul; 359(4):405-14. PubMed ID: 18650517
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
    Takeuchi K; Choi YL; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Takada S; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H
    Clin Cancer Res; 2008 Oct; 14(20):6618-24. PubMed ID: 18927303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
    Suzuki M; Shigematsu H; Iizasa T; Hiroshima K; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
    Cancer; 2006 May; 106(10):2200-7. PubMed ID: 16598760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK status in a primary lung tumour and metachronous metastases.
    Salido M; Pijuan L; Galván AB; Gimeno J; Cañadas I; Rodriguez-Rivera M; Rojo F; Albanell J; Solé F; Arriola E
    Histopathology; 2012 Apr; 60(5):843-5. PubMed ID: 22236334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.